According to filings with the U.S. Securities and Exchange Commission, Feon Energy is raising up to $8,074,996.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Wenxiao Huang played a…
According to filings with the U.S. Securities and Exchange Commission, Biomakers is raising up to $7,999,999.00 in new funding. Sources indicate that as part of senior management President, Nicolas Kirchuk played a key role in…
According to filings with the U.S. Securities and Exchange Commission, Sports Innovation Lab is raising up to $5,155,065.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Josh Walker played…
According to filings with the U.S. Securities and Exchange Commission, Kuva Systems is raising up to $8,000,000.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Stefan Bokaemper played a…
According to filings with the U.S. Securities and Exchange Commission, Epicore Biosystems is raising up to $10,000,000.00 in new funding. Sources indicate that as part of senior management President and Chief Executive Officer, Roozbeh Ghaffari…
According to filings with the U.S. Securities and Exchange Commission, Entact Bio is raising up to $39,899,999.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Victoria Richon played a…
According to filings with the U.S. Securities and Exchange Commission, Cohere Health is raising up to $50,000,000.00 in new funding. Sources indicate that as part of senior management Director, David Barrett played a key role…
According to filings with the U.S. Securities and Exchange Commission, Biosim is raising up to $12,250,000.00 in new funding. Sources indicate that as part of senior management President, Garegin Papoian played a key role in…
According to filings with the U.S. Securities and Exchange Commission, Fractyl Health is raising $110,000,000.00 in new funding. About Fractyl Health: Fractyl Health is a leader in creating innovative therapies to address the root cause…
According to filings with the U.S. Securities and Exchange Commission, Corbus Pharmaceuticals Holdings, Inc. is raising $82,200,000.00 in new funding. About Corbus Pharmaceuticals Holdings, Inc.: Corbus Pharmaceuticals Holdings, Inc., a biopharmaceutical company, develops products to…